- Home
- LVO vs ABVC Comparison
LVO vs ABVC Comparison
Compare LVO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- ABVC
- Stock Information
- Founded
- LVO 2009
- ABVC 2015
- Country
- LVO United States
- ABVC United States
- Employees
- LVO N/A
- ABVC N/A
- Industry
- LVO Restaurants
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- ABVC Health Care
- Exchange
- LVO Nasdaq
- ABVC Nasdaq
- Market Cap
- LVO 65.1M
- ABVC 52.1M
- IPO Year
- LVO N/A
- ABVC N/A
- Fundamental
- Price
- LVO $5.58
- ABVC $2.96
- Analyst Decision
- LVO Strong Buy
- ABVC
- Analyst Count
- LVO 1
- ABVC 0
- Target Price
- LVO $13.00
- ABVC N/A
- AVG Volume (30 Days)
- LVO 136.5K
- ABVC 86.5K
- Earning Date
- LVO 11-11-2025
- ABVC 11-13-2025
- Dividend Yield
- LVO N/A
- ABVC N/A
- EPS Growth
- LVO N/A
- ABVC N/A
- EPS
- LVO N/A
- ABVC N/A
- Revenue
- LVO $100,534,000.00
- ABVC $391,242.00
- Revenue This Year
- LVO N/A
- ABVC $735.18
- Revenue Next Year
- LVO $25.61
- ABVC N/A
- P/E Ratio
- LVO N/A
- ABVC N/A
- Revenue Growth
- LVO N/A
- ABVC 186.84
- 52 Week Low
- LVO $3.92
- ABVC $0.40
- 52 Week High
- LVO $16.00
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- LVO 74.64
- ABVC 50.34
- Support Level
- LVO $4.34
- ABVC $2.76
- Resistance Level
- LVO $4.93
- ABVC $3.06
- Average True Range (ATR)
- LVO 0.38
- ABVC 0.17
- MACD
- LVO 0.01
- ABVC -0.02
- Stochastic Oscillator
- LVO 79.25
- ABVC 34.35
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.